A. Sponghini

发表

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma

S. Marceglia, A. Vingiani, L. De Cecco, 2020, Cancers.

Complete response to anti-PD-1 nivolumab in massive skin metastasis from melanoma: efficacy and tolerability in an elderly patient

P. Savoia, A. Sponghini, R. Giorgione, 2017, Anti-cancer drugs.

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

L. De Cecco, S. Canevari, S. Pilotti, 2017, Disease markers.

Bevacizumab Treatment for Vestibular Schwannoma in a Patient with Neurofibromatosis Type 2: Hearing Improvement and Tumor Shrinkage

R. Soffietti, F. Platini, A. Sponghini, 2015, Tumori.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab

L. De Cecco, S. Canevari, S. Pilotti, 2016, Clinical Cancer Research.

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

F. Caponigro, R. Miceli, G. Rinaldi, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study

L. Mainardi, F. Caponigro, G. Rinaldi, 2021, Diagnostics.

Primary Ewing's sarcoma of the sinonasal tract, eroding the ethmoid and sphenoid sinus with intracranial extension: A rare case report.

R. Boldorini, L. Masini, M. Lombardi, 2015, Molecular and clinical oncology.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, Ludmila V. Danilova, David C. Smith, 2016, Journal of Translational Medicine.

A Simon's two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities

D. Ferrante, C. Magnani, A. Gennari, 2021, Journal of traditional and complementary medicine.

Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme

Eleonora Soligo, A. Stecco, A. Carriero, 2019, The neuroradiology journal.

An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer

F. Caponigro, L. De Cecco, S. Canevari, 2022, Cells.

The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts).

L. Mariani, L. Licitra, C. Resteghini, 2021 .

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study

P. Queirolo, M. Del Vecchio, V. Chiarion Sileni, 2023, Cancers.

Vitiligo-like depigmentation patterns in patients receiving immunotherapy for metastatic melanoma

P. Savoia, L. C. Gironi, A. Sponghini, 2021 .